Ways into Understanding HIF Inhibition

Area of Science:

• Oncology
• Molecular Biology
• Drug Discovery

Background:

• Hypoxia, or low oxygen, is a hallmark of tumor microenvironments.
• Cancer cells activate hypoxia-inducible factors (HIFs) to survive and proliferate under hypoxic conditions.
• HIF pathway dysregulation is implicated in numerous solid and liquid cancers.

Purpose of the Study:

• To review current classes of HIF pathway inhibitors.
• To explore in vitro and in vivo techniques for understanding inhibitor mechanisms.
• To highlight the importance of elucidating inhibitor modes of action for clinical application.

Main Methods:

• Review of existing literature on HIF inhibitors.
• Discussion of various in vitro and in vivo methodologies.
• Exploration of advanced imaging techniques (luminescent, fluorescent, nanobodies) and chromatin immunoprecipitation.

Main Results:

• Several drug candidates targeting HIF pathway interactions and transcription are in development, with some in clinical trials.
• Open questions persist regarding the precise mechanisms of action for many HIF inhibitors.
• Novel imaging and molecular techniques offer potential to clarify these mechanisms.

Conclusions:

• Understanding the specific mechanisms of HIF inhibitors is essential for their successful clinical translation.
• Elucidating inhibitor action is critical for optimizing efficacy and ensuring the safety of novel anticancer therapies.
• Further research employing advanced techniques will accelerate the development of targeted HIF-inhibiting cancer treatments.